FIELD: chemistry.
SUBSTANCE: invention relates to fluorine containing compounds of formula III:
,
where R3 is selected from group comprising H, F, CN and NO2; R7 is selected from group comprising Y, -O(CH2)n-Y, -(OCH2CH2)m-Y, Z, -OCH2-Z; -CH2-CH2-Z, -CH=CH-Z and -C≡C-Z; X is selected from CH or N; Y is selected from 18F or F; Z is a group
,
where * indicates the atom of connection of Z; R5 is selected from group comprising H, CN and NO2; R8 is selected from group comprising Y and -O(CH2)n-Y; n is a 1-3; and m is a 2-3; including E-and Z-isomers and diastereomers, mixtures thereof, and any pharmaceutically acceptable salt or their complex, as well as methods for production thereof, intermediate synthesis compounds.
EFFECT: use of salts as diagnostic agents, especially for imaging thrombi.
14 cl, 6 tbl, 55 ex
Title | Year | Author | Number |
---|---|---|---|
NONSTEROIDAL MODULATORS OF GLUCOCORTICOID RECEPTORS FOR LOCAL DRUG DELIVERY | 2016 |
|
RU2731618C2 |
PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
NOVEL COMPOUND EXHIBITING ENTEROPEPTIDASE INHIBITING ACTIVITY | 2019 |
|
RU2768755C1 |
INHIBITORS OF LYSINE-SPECIFIC GINGIPAIN | 2015 |
|
RU2728785C2 |
NOVEL ISOINDOLINE OR ISOQUINOLINE COMPOUNDS, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2014 |
|
RU2689305C2 |
GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2664533C2 |
LIGAND CONJUGATE WITH CYTOTOXIC DRUG PREPARATION, METHOD AND APPLICATION THEREOF | 2016 |
|
RU2708461C2 |
DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS | 2014 |
|
RU2662951C2 |
NEW CONJUGATES BINDING COMPOUND - ACTIVE COMPOUND (ADC) AND USE THEREOF | 2012 |
|
RU2610336C2 |
PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | 2013 |
|
RU2661896C2 |
Authors
Dates
2016-09-10—Published
2012-08-17—Filed